MedPath

The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

Not Applicable
Completed
Conditions
HIV Infections
Mycobacterium Avium-intracellular Infection
Registration Number
NCT00002336
Lead Sponsor
Abbott
Brief Summary

To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts \<= 100 cells/mm3.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (22)

Univ of Arizona / Health Science Ctr

🇺🇸

Tucson, Arizona, United States

California Med Research Group

🇺🇸

Fresno, California, United States

HIV Research Group

🇺🇸

San Diego, California, United States

Saint Francis Mem Hosp

🇺🇸

San Francisco, California, United States

Kaiser Permanente Med Ctr

🇺🇸

San Francisco, California, United States

Santa Clara Valley Med Ctr

🇺🇸

San Jose, California, United States

TheraFirst Med Ctrs Inc

🇺🇸

Fort Lauderdale, Florida, United States

Dr Nelson Zide

🇺🇸

Hollywood, Florida, United States

Infectious Disease Research Institute Inc

🇺🇸

Tampa, Florida, United States

Indiana Univ Hosp

🇺🇸

Indianapolis, Indiana, United States

Scroll for more (12 remaining)
Univ of Arizona / Health Science Ctr
🇺🇸Tucson, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.